SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Interim Management Statement

19 Jan 2012 07:00

RNS Number : 8030V
Oxford Instruments PLC
19 January 2012
 



Oxford Instruments plc

 

Interim Management Statement

 

19 January 2012

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 October 2011 to date.

Orders within both our Research and Industrial markets remained robust with the exception that, as expected, orders for High Brightness LED related equipment within our Plasma Technology business unit have fallen as overcapacity in this industry takes effect. Despite this, orders, sales and profits for the Group for the year to date and for the third quarter are ahead of the corresponding period last year and consistent with our expectations.

On 20 October 2011 the Group disposed of a non-core Industrial product line that we produced for a single customer, to that customer. A consideration of £7.1 million was paid on completion, with a further £1.0 million receivable on the completion of a Transitional Services Agreement.

On 4 November 2011 the Group announced the acquisition of Platinum Medical Imaging LLC (Platinum) for an initial debt free, cash free consideration of US$18 million with a deferred element of up to US$37 million payable over three years dependent on its performance over that period. The combination of Platinum with our existing MRI Service business in North America significantly strengthens the Group's Service Sector offering, and its integration is progressing to plan.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

Our broad spread of geographies and technologies, and our strong pipeline of new products should help us to remain resilient in the event of a global economic downturn. The Board anticipates that Oxford Instruments will continue to make good progress in line with its expectations for the remainder of the financial year and consistent with its 14 cubed objectives.

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Ian Payne

 

 

This Interim Management Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the Statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

 

 

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is a member of the FTSE250 index on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its' products, expertise, and ideas address global issues such as energy, environment and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDBGDBBGDI
Date   Source Headline
3rd Jul 20231:39 pmPRNTotal Voting Rights
13th Jun 20237:00 amRNSPreliminary Results
13th Apr 20237:00 amRNSCEO succession
13th Apr 20237:00 amRNSTrading Update
1st Dec 202211:09 amRNSTotal Voting Rights
8th Nov 20227:00 amRNSHalf-Year Results
13th Oct 20227:00 amRNSHalf Year Trading Update
1st Sep 20227:00 amRNSAppointment of Joint Broker
29th Jul 20228:56 amRNSAppointment of Independent Non-Executive Director
21st Jul 20222:12 pmRNSHolding(s) in Company
18th Jul 20224:20 pmRNSHolding(s) in Company
15th Jul 20222:07 pmRNSDirector/PDMR Shareholding
11th Jul 202211:10 amRNSDirector/PDMR Shareholding
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSPreliminary Results
1st Jun 202210:44 amPRNTotal Voting Rights
31st May 20224:35 pmRNSPrice Monitoring Extension
13th Apr 20221:54 pmPRNHolding(s) in Company
13th Apr 20227:00 amRNSTrading Update
11th Apr 20223:21 pmPRNDirector/PDMR Shareholding
8th Apr 20228:56 amPRNHolding(s) in Company
15th Mar 20228:50 amPRNDirector Declaration
10th Mar 20223:07 pmPRNDirector/PDMR Shareholding
8th Mar 20223:20 pmRNSForm 8.3 - Oxford Instruments plc
8th Mar 20222:53 pmRNSForm 8.5 (EPT/RI)-Oxford Instruments plc Amend
8th Mar 202212:14 pmRNSForm 8.3 - [Oxford Instruments plc]
8th Mar 202211:29 amRNSForm 8.5 (EPT/RI)-Oxford Instruments plc
8th Mar 202211:06 amRNSForm 8.3 - Oxford Instruments Plc
7th Mar 20224:54 pmRNSForm 8.5 (EPT/RI)-Oxford Instruments plc Amend
7th Mar 20223:31 pmRNSForm 8.3 - Oxford Instruments plc
7th Mar 20223:21 pmRNSForm 8.3 - OXFORD INSTRUMENTS GROUP PLC
7th Mar 20223:20 pmRNSForm 8.3 - Oxford Instruments plc
7th Mar 20223:19 pmRNSForm 8.3 - Spectris plc
7th Mar 20223:02 pmRNSForm 8.3 - Oxford Instruments PLC
7th Mar 20222:09 pmRNSForm 8.3 -Oxford Instruments plc
7th Mar 20221:40 pmRNSForm 8.3 - Oxford Instruments plc
7th Mar 20221:06 pmGNWForm 8.3 - [Oxford Instruments plc - 04 03 2022] - (HHL)
7th Mar 202212:36 pmRNSForm 8.3 - Oxford Instruments PLC
7th Mar 202212:25 pmRNSForm 8.3 - Oxford Instruments
7th Mar 202211:48 amRNSForm 8.3 - [Oxford Instruments plc]
7th Mar 202211:20 amRNSForm 8.5 (EPT/NON-RI)-Oxford Instruments plc
7th Mar 202211:08 amGNWMan Group PLC : Form 8.3 - Oxford Instruments plc
7th Mar 202211:03 amRNSForm 8.5 (EPT/RI)-Oxford Instruments plc
7th Mar 202210:50 amRNSForm 8.3 - [Spectris Plc]
7th Mar 202210:41 amRNSForm 8.3 - Oxford Instruments Plc
7th Mar 20229:26 amRNSForm 8.5 (EPT/NON-RI) Oxford Instruments Plc
7th Mar 20227:02 amRNSResponse to Spectris plc no intention to bid stmt
7th Mar 20227:00 amRNSOffer Talks Terminated
4th Mar 20224:36 pmRNSForm 8.5 (EPT/RI)-Oxford Instruments plc Amend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.